FDA Ruling on Statin Therapy

Published Online: Wednesday, December 19, 2012
Follow Pharmacy_Times:
In this video, David Dichek, MD, of the University of Washington Medical Center, discusses an FDA warning regarding the potential for cognitive problems and elevated blood sugar associated with taking statins. He also discusses how to address concerns that patients may have about taking statins in light of the waning.

Related Articles
Only 1 in 3 older adults with diabetes meet the American Diabetes Association’s treatment targets for blood glucose, cholesterol, and blood pressure.
Karen J. McConnell, Pharm.D., FCCP, BCPS, gives advice to pharmacists who are counseling patients for statin therapy.
Acute coronary syndrome is clearly a problem in the elderly population, especially since survival declines with increasing age.
Abbott’s new blood glucose meter is now widely available OTC without insurance co-pays.
Latest Issues
$auto_registration$